Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence

Recurrent major depressive disorder (rMDD) is a relapsing-remitting disease with high morbidity and a 5-year risk of recurrence of up to 80%. This was a prospective pilot study to examine the potential diagnostic and prognostic value of targeted plasma metabolomics in the care of patients with rMDD...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transl Psychiatry
Autori principali: Mocking, Roel J. T., Naviaux, Jane C., Li, Kefeng, Wang, Lin, Monk, Jonathan M., Bright, A. Taylor, Figueroa, Caroline A., Schene, Aart H., Ruhé, Henricus G., Assies, Johanna, Naviaux, Robert K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7801396/
https://ncbi.nlm.nih.gov/pubmed/33431800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-020-01182-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi